Cargando…
Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1
T cells use highly diverse receptors (TCRs) to identify tumor cells presenting neoantigens arising from genetic mutations and establish anti-tumor activity. Immunotherapy harnessing neoantigen-specific T cells to target tumors has emerged as a promising clinical approach. To assess whether a compreh...
Autores principales: | Poran, Asaf, Scherer, Julian, Bushway, Meghan E., Besada, Rana, Balogh, Kristen N., Wanamaker, Amy, Williams, Reid G., Prabhakara, Jasmina, Ott, Patrick A., Hu-Lieskovan, Siwen, Khondker, Zakaria S., Gaynor, Richard B., Rooney, Michael S., Srinivasan, Lakshmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691446/ https://www.ncbi.nlm.nih.gov/pubmed/33294862 http://dx.doi.org/10.1016/j.xcrm.2020.100141 |
Ejemplares similares
-
A universal MHCII technology platform to characterize antigen-specific CD4(+) T cells
por: Vyasamneni, Rohit, et al.
Publicado: (2023) -
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
por: Zhou, Weijun, et al.
Publicado: (2022) -
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
por: Pang, Zhi, et al.
Publicado: (2023) -
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes
por: Poran, Asaf, et al.
Publicado: (2020) -
The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
por: Karpanen, Terhi, et al.
Publicado: (2017)